Literature DB >> 18670424

Pharma pursues novel models for academic collaboration.

Bethan Hughes.   

Abstract

Mesh：

Year:  2008        PMID： 18670424     DOI： 10.1038/nrd2648

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  6 in total

1.  IUPHAR-DB: an open-access, expert-curated resource for receptor and ion channel research.

Authors:  Joanna L Sharman; Chidochangu P Mpamhanga
Journal:  ACS Chem Neurosci       Date:  2011-05-18       Impact factor: 4.418

Review 2.  The importance of new companies for drug discovery: origins of a decade of new drugs.

Authors:  Robert Kneller
Journal:  Nat Rev Drug Discov       Date:  2010-10-29       Impact factor: 84.694

3.  Open innovation networks between academia and industry: an imperative for breakthrough therapies.

Authors:  Teri Melese; Salima M Lin; Julia L Chang; Neal H Cohen
Journal:  Nat Med       Date:  2009-05       Impact factor: 53.440

4.  News feature: 2008 in reflection.

Authors:  Bethan Hughes
Journal:  Nat Rev Drug Discov       Date:  2009-01       Impact factor: 84.694

5.  The case for open-access chemical biology. A strategy for pre-competitive medicinal chemistry to promote drug discovery.

Authors:  Johan Weigelt
Journal:  EMBO Rep       Date:  2009-09       Impact factor: 8.807

6.  Helping science and drug development to succeed through pharma-academia partnerships: Yale Healthcare Conference 2013.

Authors:  Daniel X Yang; Yunsoo A Kim
Journal:  Yale J Biol Med       Date:  2013-09-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.